“In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors”. Journal of Pharmaceutical Negative Results, Feb. 2023, pp. 2793-0, https://doi.org/10.47750/pnr.2023.14.S02.329.